Demystifying the Canadian Drug and Health Products Regulatory Landscape

This webinar will give you a snap shot of what is current trends, what is coming and what this means to anyone who is currently developing Drugs and other Health Products for the Canadian market. The focus will be on drugs, biologics and medical devices, We will also be providing an overview of how the regulatory landscape is currently evolving for most efficient strategic planning.

Susanne Picard
Instructor:
Susanne Picard
Date:
Tuesday, June 25, 2019
Time:
08:00 AM PDT | 11:00 AM EDT
Duration:
60 Minutes

More Trainings by this Expert   Product Id : 502455

Price Details
$150 Live
$290 Corporate Live
$190 Recorded
$390 Corporate Recorded
Combo Offers
Live + Recorded
$289 $340 Live + Recorded
Corporate (Live + Recorded)
$599 $680 Corporate
(Live + Recorded)
Price Detail Options
Overview:

In this webinar, we will demystify broadly what the current Canadian regulatory landscape is for efficient Canadian development initiatives.

We will also be providing an overview of how the regulatory landscape is currently evolving for most efficient strategic planning.

Why should you Attend: Understanding a regulatory landscape is key to decision making; understanding how it is evolving is an important aspect of strategic planning.

This webinar will give you a snap shot of what is current, what is coming and what this means to anyone who is currently developing Drugs and other Health Products for the Canadian market. The focus will be on drugs, biologics and medical devices.

Areas Covered in the Session:

  • Current regulatory & submission requirements for drugs, biologics and medical devices as required by Canada's Regulatory Agency, Health Canada
  • Major initiatives and up-coming changes in the regulatory environment, including use of foreign reviews / decisions, international collaboration, improved access to different drugs, expansion of priority review pathways, the use of real-world evidence, the Medical Device Single Audit Program, and the digital health review division
  • Best approaches for working with Health Canada in any drug and & health product development plan

Who Will Benefit:
  • Regulatory
  • Pharma
  • Biotech Executives
  • Decision Makers


Speaker Profile
Susanne Picard Founder and President of SPharm, is a sought-after expert on all aspects of the regulatory landscape. SPharm is a leading regulatory affairs consultancy headquartered in Canada that services clients around the globe.




Your Recently Viewed Webinars

Payment Methods

Contact Us

NetZealous LLC,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.

Information

  Refund Policy
  +1-800-447-9407
  Fax: 302 288 6884
  support@compliance4All.com